Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Drug candidate and target for leishmaniasis

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 560, 171-172 (2018)



  1. Alvar, J. et al. PLoS ONE 7, e35671 (2012).

    Article  PubMed  Google Scholar 

  2. Wyllie, S. et al. Nature 560, 192–197 (2018).

    Article  Google Scholar 

  3. Vianna, G. Anais do 70 Congresso Brasileiro de Medicina e Cirurgia 4, 426–428 (1912).

    Google Scholar 

  4. Brahmachari, U. A Treatise on Kala Azar (John Bale, Sons & Danielsson, 1928).

    Google Scholar 

  5. World Health Organization. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis (WHO, 2012).

    Google Scholar 

  6. Ferguson, F. M. & Gray, N. S. Nature Rev. Drug Discov. 17, 353–357 (2018).

    Article  PubMed  Google Scholar 

  7. Field, M. C. et al. Nature Rev. Microbiol. 15, 217–231 (2017).

    Article  PubMed  Google Scholar 

  8. Beneke, T. et al. R. Soc. Open Sci. 4, 170095 (2017).

    Article  PubMed  Google Scholar 

  9. Jones, N. G., Catta-Preta, C. M. C., Lima, A. P. C. A. & Mottram, J. C. ACS Infect. Dis. 4, 467–477 (2018).

    Article  PubMed  Google Scholar 

  10. Khare, S. et al. Nature 537, 229–233 (2016).

    Article  PubMed  Google Scholar 

  11. van Griensven, J. et al. Lancet Infect. Dis. 10, 184–194 (2010).

    Article  PubMed  Google Scholar 

  12. Rai, K. et al. mBio 4, e00611–13 (2013).

    Article  PubMed  Google Scholar 

Download references


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links